Ian Jacobs

ORCID: 0000-0002-5005-2672 · 7 papers in corpus · active 1989-2018

Study types

  • article 3
  • other 2
  • letter 1
  • review 1

Condition tags

  • endometriosis 3
  • infertility 2
other 2018
BMJ (Clinical research ed.) ·doi:10.1136/bmj.k2644

OBJECTIVE: To investigate the risks of ovarian, breast, and corpus uteri cancer in women who have had assisted reproduction. DESIGN: Large, population based, data linkage cohort study. SETTING AND PARTICIPANTS: All women who had assisted …

article 2015
·doi:10.1016/j.fertnstert.2015.07.112
letter 2014
·doi:10.1002/uog.13354

We thank Ludovisi et al. for their interest in our paper and for undertaking a retrospective analysis of data collected from symptomatic women attending their department for clinical evaluation. The authors note visualization rates of over …

article 2014
·doi:10.1136/bmjopen-2013-004421

OBJECTIVE: To evaluate the validity of self-reported hysterectomy against the gold standard of uterine visualisation using pelvic ultrasound. DESIGN: Prospective cohort study. SETTING: UK Collaborative Trial of Ovarian Cancer Screening (UKC…

other 2013
Journal of proteome research ·doi:10.1021/pr3010474

The CA125 biomarker assay plays an important role in the diagnosis and management of primary invasive epithelial ovarian/tubal cancer (iEOC). However, a fundamental problem with CA125 is that it is not cancer-specific and may be elevated in…

article 2004
·doi:10.1089/1090657041797202

Women who are at increased risk of developing ovarian cancer because of their family history may need to make decisions about the medical management of their cancer risk—whether to have ovarian screening or undergo prophylactic surgery. Thi…

review 1989
Human Reproduction ·doi:10.1093/oxfordjournals.humrep.a136832

CA 125 is an antigenic determinant on a high-molecular-weight glycoprotein recognized by a monoclonal antibody which was raised using an ovarian cancer cell line as an immunogen. During the last 5 years the studies reviewed in this paper ha…